María Adelaida Gómez

10PUBLICATIONS
8CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 03, 2026
Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment.

|Apr 04, 2025
Innate biosignature of treatment failure in human cutaneous leishmaniasis.

María Adelaida Gómez, Ashton Trey Belew, Deninson Alejandro Vargas

|May 15, 2024
Innate biosignature of treatment failure in human cutaneous leishmaniasis.

Maria Adelaida Gómez, Ashton Trey Belew, Deninson Vargas

|Jan 17, 2024
Consolidation of a Molecular Signature of Healing in Cutaneous Leishmaniasis Is Achieved during the First 10 Days of Treatment.

Lina Giraldo-Parra, David E Rebellón-Sánchez, Adriana Navas

|Mar 08, 2023
Quality parameters for RNA preparations from biopsies of ulcerated human skin.

Lina Giraldo-Parra, Lady Giovanna Ramirez, Adriana Navas

|Sep 23, 2022
Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy.

Martha Lucía Díaz, Karl Burgess, Richard Burchmore

Pageof 2

Frequent Collaborators

4 joint publications

Lina Giraldo-Parra

3 joint publications

Najib M El-Sayed

2 joint publications

David E Rebellón-Sánchez

1 joint publications

Diana J Garay-Baquero